samedan logo
 
 
spacer
home > ebr > autumn 2001 > biotechnology and patents from the finnish point of view
PUBLICATIONS
European BioPharmaceutical Review

Biotechnology and Patents From the Finnish Point of View

During the 80s and 90s, there was a remarkable investment boom in Finland in the biotechnological sector, and this trend is still continuing. With more than 115 biotechnology companies, Finland can be ranked amongst the top European countries in terms of number of biotechnological firms.Biotechnology comprises a large sector. Approximately half the businesses operating in Finland concentrate on health products such as pharmaceuticals. In general terms, the use of biotechnology in the pharmaceutical industry is increasing. It is estimated that biotechnology has been used in every fifth new pharmaceutical brought onto the market.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EuroBiopartnering 2008

7-9 October 2008, Paris, France

EuroBiOpartnering 2008 gives you the unique opportunity to meet the relevant decision makers and opinion leaders from the international biotech community and offers you 3 days of partnering opportunities including one-to-one meetings, company presentations and further networking activities…
More info >>

 
News and Press Releases

Ultra slim and ultra quick


More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement